Safety concerns raised over people with peripheral field loss

Article

Poor traffic gap judgement in patients with peripheral field loss (PFL) raises important safety concerns for their safety when crossing the road.

Poor traffic gap judgement in patients with peripheral field loss (PFL) raises important safety concerns for their safety when crossing the road, according to a study published online by Optometry & Vision Science.

Allen Cheong and colleagues from The Minnesota Laboratory for Low-Vision Research, University of Minnesota, USA recruited eight subjects with significant PFL and five age-matched control subjects. Each subject was asked to judge when they perceived it to be safe to cross a two-way, four-lane street while they stood on the curb. Eye movements were recorded by an eye tracker and movies of the eye-on-scene were made offline. Fixation patterns were classified into either relevant or irrelevant. Patients' street-crossing behaviour, habitual approach to street crossing and perceived difficulties were also assessed.

Compared with normal vision subjects, the PFL subjects identified 12% fewer crossable gaps while making 23% more errors by identifying a gap as crossable when it was, in fact, too short (p<0.05). These differences may be explained by the significantly smaller fixation area (p=0.006) and fewer fixations distributed to the relevant tasks (p=0.001). The patients' habitual approach to street crossing and perceived difficulties in street crossing were significantly correlated with traffic gap judgment performance.

The poor traffic gap judgment of patients with peripheral field loss raises concerns about their safety in crossing streets.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.